Companies / Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc.

Nasdaq: DRMACIK 1853816SAN DIEGO, CA

Financials

Revenue—
Net income$-7.56M
Total debt—
Cash$4.41M
Diluted EPS$-8.16
Shares outstanding4.0M

Ownership

4.0M shares outstanding · as of Aug 10, 2026
0.03%Insiders
Ownership
Insiders0.03%1,012
10%+ / strategic1.34%53,910
Institutions57.42%2,309,542
Public float41.21%1,657,679

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Bedoya-Toro Munera Maria ESVP, Regulatory Affairs
0.03%1,012
Bradrick BrittanyDirector
——
Fisher MaryDirector
——
Hale David FDirector
——
Mento Steven JDirector
——
Nardo Christopher J.Senior VP, CDO
——
Proehl Gerald TCEOPresident, CEO and Chairman · Director · 10% owner
——
Sandler Andrew SethDirector
——
Scott Kathleen D.Director
——
Van Hoose Kyri K.SVP, CFO
——

Institutional holders 31

View all →
HolderValue% of shares
Armistice Capital, LLC$464.9K38.84%
Citadel Advisors LLC$187.3K15.65%
Vanguard Group Inc$131.2K10.95%
Squarepoint Ops LLC$113.4K9.48%
Geode Capital Management, LLC$58.5K1.20%
Susquehanna International Group, LLP$40.9K3.42%
Clear Street Group Inc.$39.4K0.42%
XTX Topco Ltd$39.1K3.27%
Jane Street Group, LLC$36.6K3.06%
BNP Paribas Financial Markets$36.3K3.04%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 17, 2026Bedoya-Toro Munera Maria E
Executive
BuyCommon Stock$1.3K+1K
+8333.33%
1,012
0.03% of shares
low
Jan 2, 2026Van Hoose Kyri K.
Executive
GrantStock Option (right to buy)—+18K
18,000
0.45% of shares
low
Jan 2, 2026Nardo Christopher J.
Executive
GrantStock Option (right to buy)—+18K
18,000
0.45% of shares
low
Jan 2, 2026Bradrick Brittany
Director
GrantStock Option (Right to Buy)—+3K
2,500
0.06% of shares
low
Jan 2, 2026Scott Kathleen D.
Director
GrantStock Option (Right to Buy)—+3K
2,500
0.06% of shares
low
Jan 2, 2026Sandler Andrew Seth
Director
GrantStock Option (Right to Buy)—+3K
2,500
0.06% of shares
low
Jan 2, 2026Bedoya-Toro Munera Maria E
Executive
GrantStock Option (right to buy)—+9K
9,000
0.22% of shares
low
Jan 2, 2026Mento Steven J
Director
GrantStock Option (Right to Buy)—+3K
2,500
0.06% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Bigger Capital Fund L PPassive13G/A———
Armistice Capital, LLCPassive13G/A—53,910—
Armistice Capital, LLCPassive13G/A—53,910—
Mitchell P. KopinPassive13G———
Bigger Capital Fund L PPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DRMACommon StockEquity249845504BBG011DJT0X2
DRMA——84841L407—